Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review

by Locke D. Uppendahl, Carly M. Dahl, Jeffrey S. Miller, Martin Felices, Melissa A. Geller
Published 2018-01-01

A qualitative study of barriers to genetic counseling and potential for mobile technology education among women with ovarian cancer

by Rachel Isaksson Vogel, Kristin Niendorf, Heewon Lee, Sue Petzel, Hee Yun Lee, Melissa A. Geller
Published 2018-07-01

A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer

by Daniel A. Vallera, Felix Oh, Behiye Kodal, Peter Hinderlie, Melissa A. Geller, Jeffrey S. Miller, Martin Felices
Published 2021-08-01

A multiplex platform for the identification of ovarian cancer biomarkers

by Kristin L. M. Boylan, Kate Geschwind, Joseph S. Koopmeiners, Melissa A. Geller, Timothy K. Starr, Amy P. N. Skubitz
Published 2017-10-01

Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy

by Pamela C. Rosato, Sathi Wijeyesinghe, J. Michael Stolley, Christine E. Nelson, Rachel L. Davis, Luke S. Manlove, Christopher A. Pennell, Bruce R. Blazar, Clark C. Chen, Melissa A. Geller, Vaiva Vezys, David Masopust
Published 2019-02-01

NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo

by Daniel A. Vallera, Soldano Ferrone, Behiye Kodal, Peter Hinderlie, Laura Bendzick, Brianna Ettestad, Caroline Hallstrom, Nicholas A. Zorko, Arpit Rao, Naomi Fujioka, Charles J. Ryan, Melissa A. Geller, Jeffrey S. Miller, Martin Felices
Published 2020-09-01

A 78-Year-Old Infertile Man Presented With Sepsis and Abdominal and Pelvic Masses, A Rare Case of Congenital Adrenal Hyperplasia

by Jamil B. Alkhaddo, MD, Ameer Khowaja, MD, Asad Saeed, MD, Katherine Cotter, MD, Colleen Rivard, MD, Melissa A. Geller, MD, MS, Elizabeth Louise Dickson, MD, Christopher J. Weight, MD, MS, James Redmon, MD
Published 2016-01-01